Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pluristem Therapeutics Inc

+ Add to Watchlist

PSTI:IT

1,131.00 ILs 37.00 3.17%

As of 11:24:12 ET on 03/26/2015.

Snapshot for Pluristem Therapeutics Inc (PSTI)

Open: 1,132.00 Day's Range: 1,125.00 - 1,146.00 Volume: 158,395
Previous Close: 1,168.00 52wk Range: 909.10 - 1,506.00 1-Yr Rtn: -11.64%

Stock Chart for PSTI

No chart data available.
  • PSTI:IT 1,130.00
  • 1D
  • 1M
  • 1Y
1,168.00
Interactive PSTI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PSTI

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. TA-100 -
Earnings Per Share (USD) (ttm) -0.4100
Est. EPS (USD) (06/2015) -0.4300
Est. PEG Ratio -
Market Cap (M ILS) 797.67
Shares Outstanding (M) 70.53
30 Day Average Volume 226,070
Price/Book (mrq) 4.0847
Price/Sale (ttm) 505.3552
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PSTI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PSTI

Pluristem Therapeutics, Inc. develops Messenchymal stem cell production technology and commercializes cell therapy products. The Company focuses on cell therapy to treat severe blood, cardiovascular, autoimmune, and other disorders.

Zami AbermanChief Executive OfficerYaky YanayPresident/CFO/COO
More Company Profile & Key Executives for PSTI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil